Multivalent, asymmetric IL-2 –Fc fusions show enhanced selectivity for regulatory T cells | Science Signaling
Engineering an α chain–biased, multivalent IL-2 may improve its utility in treating autoimmunity.
Source: Signal Transduction Knowledge Environment - Category: Science Source Type: news
More News: Environmental Health | Science